Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD73 Antikörper

NT5E Reaktivität: Human FACS Wirt: Maus Monoclonal 4G4 unconjugated
Produktnummer ABIN2192064
  • Target Alle CD73 (NT5E) Antikörper anzeigen
    CD73 (NT5E) (5'-Nucleotidase, Ecto (CD73) (NT5E))
    Reaktivität
    • 116
    • 68
    • 31
    • 18
    • 18
    • 16
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 88
    • 39
    • 17
    • 2
    Maus
    Klonalität
    • 79
    • 67
    Monoklonal
    Konjugat
    • 58
    • 14
    • 12
    • 9
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CD73 Antikörper ist unkonjugiert
    Applikation
    • 82
    • 64
    • 46
    • 39
    • 16
    • 14
    • 14
    • 13
    • 12
    • 8
    • 7
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Sterilität
    0.2 μm filtered
    Klon
    4G4
    Top Product
    Discover our top product NT5E Primärantikörper
  • Applikationshinweise
    For immunohistochemistry and flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Positive HUVEC and fresh lymphocytes control Negative COS cells (Ref. 2) control
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS, containing 0.1 % bovine serum albumin.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Niemelä, Henttinen, Yegutkin, Airas, Kujari, Rajala, Jalkanen: "IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 3, pp. 1646-53, (2004) (PubMed).

    Airas, Niemelä, Jalkanen: "CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 10, pp. 5411-7, (2000) (PubMed).

    Airas, Niemelä, Salmi, Puurunen, Smith, Jalkanen: "Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells." in: The Journal of cell biology, Vol. 136, Issue 2, pp. 421-31, (1997) (PubMed).

    Airas, Hellman, Salmi, Bono, Puurunen, Smith, Jalkanen: "CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73." in: The Journal of experimental medicine, Vol. 182, Issue 5, pp. 1603-8, (1995) (PubMed).

    Airas, Salmi, Jalkanen: "Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 151, Issue 8, pp. 4228-38, (1993) (PubMed).

  • Target
    CD73 (NT5E) (5'-Nucleotidase, Ecto (CD73) (NT5E))
    Abstract
    NT5E Produkte
    Synonyme
    CALJA antikoerper, CD73 antikoerper, E5NT antikoerper, NT antikoerper, NT5 antikoerper, NTE antikoerper, eN antikoerper, eNT antikoerper, zgc:63784 antikoerper, NT5E antikoerper, MGC114869 antikoerper, PSPTO2277 antikoerper, 2210401F01Rik antikoerper, AI447961 antikoerper, Nt5 antikoerper, 5'-nucleotidase ecto antikoerper, 5'-nucleotidase, ecto (CD73) antikoerper, 5'-nucleotidase antikoerper, 5' nucleotidase, ecto antikoerper, NT5E antikoerper, nt5e antikoerper, nt5e.S antikoerper, PSPTO_2277 antikoerper, CBU_1233 antikoerper, MCA1322 antikoerper, Nt5e antikoerper
    Hintergrund
    The monoclonal antibody 4G4 recognizes both membrane bound and soluble human CD73, also known as ecto-5'-nucleotidase. CD73 is a 70- kDa GPI-anchored cell surface molecule and belongs to the 5'-nucleosidase family. CD73 is useful as marker for lymphocyte differentiation. It is abundantly expressed on the vascular endothelium and at a low level on certain subpopulations of human lymphocytes. Like many glycosyl-phosphatidylinositol (GPI)-anchored molecules, it transmits potent activation signals in T cells when ligated by antibodies. CD73 hydrolyzes extracellular nucleotides into membrane permeable nucleosides. Ecto-5'-nucleotidase activity is an important mediator of the anti- inflammatory effect by converting extracellular AMP into a potent anti-inflammatory substance adenosine. CD73 has been shown to function as a co-stimulatory molecule in human T cells and to have a role in regulating lymphocyte adhesion. Triggering of CD73 on the surface of lymphocytes, but not on endothelial cells, results in the shedding of the CD73 and increased adhesion of lymphocytes to endothelium via LFA-1 clustering. Furthermore, CD73 has been implicated to mediate homing of skin-infiltrating lymphocytes in vivo. In B-cell chronic lymphocytic leukemia the expression of CD73 is decreased. Besides this, CD73 activity has been implicated as sensitive and useful indicator for mild zinc deficiency. The monoclonal antibody 4G4 causes a reduction in CD73 expression on lymphocytes, reduces enzyme activity, and inhibits the binding of lymphocytes to endothelial cells. Aliases Ecto-5'-nucleotidase, , EC3.1.3.5 Immunogen Inflamed synovial stroma from rheumatoid arthitis patients
    Pathways
    Synaptic Membrane, Ribonucleoside Biosynthetic Process
Sie sind hier:
Kundenservice